Contact
We welcome professional enquiries.
For education, membership, faculty, conference and partnership enquiries.
Global Newsfeed
StudyLancet review: cannabinoids in chronic non-cancer pain — updated evidence synthesisRegulatoryGermany: BfArM publishes updated guidance on medicinal cannabis prescribingStudyNEJM: CBD adjunctive therapy in treatment-resistant epilepsy — long-term follow-upRegulatoryTGA Australia releases revised Special Access Scheme statisticsBusinessTilray and Aphria file expanded EU-GMP medical cannabis distribution agreementsRegulatoryUK MHRA consults on unlicensed cannabis-based medicinal products frameworkStudyJAMA: cannabinoids in chemotherapy-induced nausea — systematic review updateBusinessCanopy Growth restructures European operations amid German market expansionRegulatorySwissmedic authorises additional medicinal cannabis product classificationsStudyIACM publishes 2026 international consensus on cannabinoid dosing in palliative careStudyLancet review: cannabinoids in chronic non-cancer pain — updated evidence synthesisRegulatoryGermany: BfArM publishes updated guidance on medicinal cannabis prescribingStudyNEJM: CBD adjunctive therapy in treatment-resistant epilepsy — long-term follow-upRegulatoryTGA Australia releases revised Special Access Scheme statisticsBusinessTilray and Aphria file expanded EU-GMP medical cannabis distribution agreementsRegulatoryUK MHRA consults on unlicensed cannabis-based medicinal products frameworkStudyJAMA: cannabinoids in chemotherapy-induced nausea — systematic review updateBusinessCanopy Growth restructures European operations amid German market expansionRegulatorySwissmedic authorises additional medicinal cannabis product classificationsStudyIACM publishes 2026 international consensus on cannabinoid dosing in palliative care